Biosimilars Launch to Market… But Will Savings Follow?
Biologics dominate prescription drug spend by hundreds of billions of dollars and this medication category is at the forefront of research and….
This author has not written his bio yet.
But we are proud to say that acrosspbirxcom contributed 21 entries already.
Biologics dominate prescription drug spend by hundreds of billions of dollars and this medication category is at the forefront of research and….
PBIRx clinical health experts discuss weight loss drugs, tick season, pharmacy costs and more…
April 27, 2023
PBIRx is proud to announce that it has been certified as a Woman Owned Small Minority Business Enterprise through the Supplier Diversity Program in the state of Connecticut. Patricia Sirowich is the founder and president of PBIRx, the premier consultant firm in the pharmacy benefit industry, providing individualized consulting and auditing services for 30 years.
March 28, 2023
PBIRx, the premier Pharmacy Benefit Consulting firm, is proud to announce that it has earned a SOC 2 Type 2 certification, demonstrating PBIRx’s commitment to integrity and protecting the privacy of clients and business partners. The certification signifies that PBIRx’s information security practices, policies, procedures, and team meet the rigorous SOC 2 Type 2 security standards.
PBIRx clinical health experts discuss drug shortages to the latest COVID news and more…
Pharmacy benefit plan costs are on the rise with increased utilization of medications for members seeking chronic weight management and treatment for type 2 diabetes. There has been a surge in prescribing of a class of drugs known as glucagon-like peptide-1 (GLP-1) agonists that mimic a natural gut hormone causing blood glucose lowering and appetite Read More